On August 17, 2016, a Pennsylvania federal judge approved a special master's recommendation of $3.9 million in fees to Finnegan client Avid Radiopharmaceuticals. The fees were awarded to Avid for its expenses defending a bad-faith patent suit by Alzheimer's Institute of America (AIA).
The fee request came as a result of a November 2010 patent infringement suit that AIA filed against Avid and the University of Pennsylvania (U Penn), alleging that Avid and U Penn infringed two of its patents. In March 2015, a judge ruled the case was "exceptional" under the 2014 Octane Fitness decision, on the basis that AIA knew that it wasn't the legal owner of the patent when they filed the suit, thus entitling Avid and Penn to attorneys' fees to defend a bad-faith action.
Award/Ranking
Finnegan Named Firm of the Year at the 2024 Managing Intellectual Property Americas Awards
April 26, 2024
Commentary
World IP Day: EPO Reveals 33% Jump in Cleantech Inventions Over Five Years
April 26, 2024
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.